Physician profile
Kraig E Bertram
NPI 1992026439
$808.03
in general payments reported to CMS, 2019-2025
15 companies · $41.31 in 2025
The $41.31 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $156 · 2021: $33.83 · 2023: $199 · 2024: $115 · 2025: $41.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $103.82 | 2019-2023 | Jornay Pm |
| Glaxosmithkline, LLC. | $91.65 | 2021-2025 | Bexsero, Pediarix, Rotarix |
| Supernus Pharmaceuticals, INC. | $88.10 | 2023-2024 | Qelbree, Qelbree |
| Neos Therapeutics, LP | $85.30 | 2019-2020 | |
| Sanofi Pasteur INC. | $80.72 | 2019 | |
| Pfizer INC. | $61.78 | 2023-2025 | |
| Sobi, INC | $61.49 | 2019-2020 | |
| Tris Pharma INC | $54.53 | 2019-2023 | Dyanavel Xr |
| Corium, LLC | $42.54 | 2023 | Azstarys |
| Abbott Laboratories | $31.22 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.60 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.21 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $22.90 | 2020 | |
| Vapotherm INC | $22.25 | 2020 | |
| Merck Sharp & Dohme LLC | $13.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kraig Bertram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.